Welcome to RECONNECT Fragile X Study Website.

Currently there are no approved therapies for the treatment of Fragile X syndrome, a rare genetic disorder.

This research study is currently enrolling individuals ages 3 to 22 years of age with Fragile X syndrome.

To see if someone you love may be able to participate, please apply to learn more.

Apply to participate in Zynerba Fragile X Syndrome clinical trial in UK

Learn more about a clinical trial evaluating an investigational treatment to see if it helps behavioural issues related to Fragile X syndrome.

Qualified participants are:

  • Between 3 and 22 years of age
  • Diagnosed via genetic testing, with Fragile X syndrome
  • In generally good health